Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Genitourinary 2Breast 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Neuroblastoma 2Central Nervous System Neoplasms 2Astrocytoma 2Vasculitis, Central Nervous System 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Stiff-Person Syndrome 1Spinal Cord Neoplasms 1Rasmussen subacute encephalitis 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Pituitary Neoplasms 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Ovarian Neoplasms 1Opsoclonus-Myoclonus Syndrome 1Neuromyelitis Optica 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1

Interventions

Therapeutics 4Flow Cytometry 4Filgrastim 4Docetaxel 4Peripheral Blood Stem Cell Transplantation 3Cyclophosphamide 3sargramostim 2liposomal amphotericin B 2Radiotherapy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Paclitaxel 2Ondansetron 2Methylprednisolone 2Itraconazole 2Irinotecan 2Immunologic Techniques 2Dexamethasone 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2Alemtuzumab 2thymoglobulin 1temsirolimus 1tanespimycin 1sacituzumab govitecan 1oblimersen 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Prednisone × CNS × Clear all
NCT00410657 2010-05-14

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Completed
53 enrolled
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Aggression, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡